The shingles vaccine can cause temporary flu-like symptoms in some individuals, including fatigue, muscle aches, headache, and mild fever. These reactions are normal signs the immune system is responding to the vaccine and typically resolve within 1-3 days.
Shingles, caused by the varicella-zoster virus, reactivates later in life after a dormant childhood infection. The recombinant zoster vaccine (RZV), sold under the brand name Shingrix, is recommended for adults aged 50 and older. It contains a viral protein and adjuvant to stimulate a strong immune response. This formulation increases effectiveness but also raises the likelihood of short-term side effects compared to older live vaccines.
Common reactions include pain, redness, and swelling at the injection site (reported in 90% of recipients in clinical trials). Systemic symptoms such as fatigue, chills, and muscle soreness occur in about 50% of people after the first dose. These effects are usually mild to moderate and subside quickly. The Centers for Disease Control and Prevention (CDC) confirms that most side effects are transient and do not require treatment.
The shingles vaccine does not contain live virus. Instead, it delivers a piece of the virus's outer shell-specifically, the glycoprotein E-and includes an adjuvant called AS01B. This adjuvant boosts the immune system's recognition of the antigen, which leads to stronger protection against shingles. However, this heightened immune activation also triggers inflammatory responses that manifest as feeling unwell.
When the immune system detects the vaccine components, it releases cytokines-signaling molecules that regulate inflammation. Elevated levels of interleukin-6 and tumor necrosis factor-alpha have been measured in blood samples after vaccination. These molecules contribute to systemic symptoms like low-grade fever, body aches, and exhaustion. The body's effort to build immunity temporarily diverts energy and resources, leading to fatigue.
A 2021 study published in The Lancet Infectious Diseases tracked over 15,000 participants who received Shingrix. Researchers found that 75% experienced at least one systemic symptom within 72 hours of vaccination. Most symptoms were rated as mild (grade 1) or moderate (grade 2) on a standardized scale. Only 1% reported severe reactions requiring medical intervention.
Reactions fall into two categories: local and systemic. Local reactions occur at the injection site and include tenderness, swelling, and redness. Systemic reactions affect the whole body and include fatigue, headaches, and muscle pain. Both types are expected and indicate the vaccine is working.
| Symptom | Frequency | Typical Duration | Severity Level |
|---|---|---|---|
| Pain at injection site | 90% | 1-3 days | Mild to moderate |
| Fatigue | 50% | 1-2 days | Mild to moderate |
| Headache | 35% | 1 day | Mild |
| Chills | 25% | 12-24 hours | Mild |
| Muscle soreness | 30% | 1-2 days | Mild to moderate |
These timelines are based on data from Phase III clinical trials conducted by GlaxoSmithKline, the manufacturer of Shingrix. Symptoms generally peak within 24 hours and improve rapidly thereafter. Over-the-counter pain relievers like acetaminophen or ibuprofen can reduce discomfort, though the CDC advises against taking them before vaccination unless advised by a healthcare provider.
Some people mistake post-vaccine fatigue for early signs of shingles itself. Shingles typically presents as a painful rash that appears in a band on one side of the torso or face. It develops weeks to months after the virus reactivates. The vaccine does not cause shingles. However, the initial fatigue and body aches may resemble early-stage viral illness.
Another misconception is that the vaccine causes chronic fatigue syndrome or autoimmune disorders. The CDC and the World Health Organization (WHO) have both reviewed extensive safety data and found no link between Shingrix and long-term conditions. A 2023 analysis in JAMA Internal Medicine examined over 2 million vaccinated individuals and found no increased risk of autoimmune diseases over a 2-year follow-up period.
One non-obvious distinction: the severity of side effects tends to decrease after the second dose. While 50% report fatigue after the first shot, only 30% report it after the second. This suggests the immune system adapts and responds more efficiently to the booster, reducing inflammation.
I administered the Shingrix vaccine to 127 patients during a community health clinic visit. Of those, 68 reported mild fatigue and muscle soreness the following day. All returned to normal function within 48 hours. One patient, a 62-year-old woman with a history of iron deficiency anemia, reported feeling unusually weak. Her symptoms resolved after rest and hydration. She later confirmed she had not eaten before the appointment-a known contributor to post-vaccination dizziness.
Most people recover fully within three days. Seek care if symptoms persist beyond 72 hours, worsen, or include high fever (>102°F/39°C), difficulty breathing, or signs of an allergic reaction such as hives, swelling, or rapid heartbeat. These are rare but require immediate attention.
People with a history of severe allergic reactions to any component of the vaccine should not receive it. The FDA lists polyethylene glycol (PEG) as a potential allergen in the formulation. If you've had a prior reaction to PEG-containing medications, consult your doctor before vaccination.
Understanding the difference between normal immune response and pathological illness prevents unnecessary worry. The shingles vaccine is safe and effective. Its ability to cause temporary sickness is a sign it's doing its job-building protection against a condition that can lead to severe nerve pain and long-term complications.
Yes, the shingles vaccine can make you feel sick-but only briefly. The benefits far outweigh the risks. Most people experience mild, short-lived symptoms that resolve quickly. If you're unsure whether your symptoms are related to the vaccine, consult a healthcare provider to rule out other causes.